Critically Illness Clinical Trial
— HHHFNCOfficial title:
The Efficiency of Heated Humidifier High-Flow Nasal Cannula Between Unheated Oxygen Therapy in Difficult Weaning Patients After Extubation in Respiratory Care Center
Verified date | September 2020 |
Source | Shin Kong Wu Ho-Su Memorial Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to assess the efficacy of Heated Humidified High-Flow Nasal Cannula compared with noninvasive positive-pressure ventilation in the prevention of extubation failure in patients with prolonged mechanical ventilation.
Status | Completed |
Enrollment | 80 |
Est. completion date | December 31, 2019 |
Est. primary completion date | December 31, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 100 Years |
Eligibility |
Inclusion Criteria: - Age: Over 20 years of age - the requirement of at least six hours of mechanical ventilation per day for at least 14 consecutive days Exclusion Criteria: - Pregnancy - Status post tracheostomy - Neuromuscular diseases - Signed "do not resuscitate" order - Unplanned extubation |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Shin Kong Wu Ho-Su Memorial Hospital | Fu Jen Catholic University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Re-intubation rate | Any placement of an endotracheal tube for any indication within 72 hours of extubation, censored at the first of hospital discharge or 72 hours after extubation. | within 72 hours of extubation | |
Secondary | Mortality rate | Mortality rate, or death rate is a measure of the number of deaths | up to 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04383730 -
Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19)
|